IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — CYCN

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents1.392.824.573.013.642.874.595.709.115.647.1720.4130.3241.1362.5070.3941.43
Accounts Receivable0.000.000.100.530.580.04----0.000.000.100.230.230.230.16----
Total Current Assets1.513.095.074.024.503.554.726.019.867.118.3421.6631.6842.8463.6872.9944.45
Property, Plant & Equipment0.070.070.000.000.000.000.000.000.000.000.000.000.000.020.110.156.61
Total Non-current Assets*5.425.425.355.355.355.355.355.355.352.983.123.403.533.694.062.7455.52
Total Assets6.938.5110.429.379.858.9010.0711.3615.2110.1011.4625.0535.2146.5367.7475.7399.97
Accounts Payable1.600.460.480.460.480.300.650.740.811.863.931.652.772.521.171.391.10
Total Current Liabilities1.841.710.880.801.070.701.281.442.344.957.538.539.859.4911.3610.5113.47
Total Non-current Liabilities*0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.0038.07
Total Liabilities*1.841.710.880.801.070.701.281.442.344.957.538.539.859.4911.3610.5151.53
Retained Earnings(275.95)(274.20)(270.22)(269.24)(268.92)(268.02)(267.30)(265.96)(262.72)(270.29)(266.11)(251.94)(241.44)(228.05)(204.30)(193.01)(176.83)
Total Stockholder Equity5.096.799.548.578.788.208.789.9212.875.153.9316.5225.3637.0356.3965.2248.43

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue0.000.001.020.880.090.081.810.19----0.000.000.000.000.610.000.310.710.530.35
Research & Development0.000.730.520.350.060.040.060.080.110.04(3.72)0.580.893.774.457.0810.229.7410.467.03
Selling, General & Admin1.772.481.341.531.711.501.251.241.281.57(0.62)2.133.363.273.513.533.523.954.414.60
Total Operating Expenses1.773.211.861.881.771.541.301.321.381.62(4.35)6.024.247.047.9610.6113.7413.7014.8711.63
Operating Income(1.77)(3.21)(0.84)(1.01)(1.67)(1.46)0.50(1.13)(1.38)(1.62)4.35(6.01)(4.24)(7.04)(7.35)(10.61)(13.43)(12.98)(14.34)(11.28)
Net Income(1.75)(3.18)(0.80)(0.98)(0.32)(1.43)0.53(0.72)(1.32)(1.54)(1.69)7.57(4.18)(6.95)(7.22)(10.50)(13.39)(12.98)(10.78)(11.29)
Basic EPS(0.41)(0.76)(0.98)(0.30)(0.11)(0.56)1.61(0.29)(0.53)(0.62)(23.59)3.11(1.83)(0.16)(1.12)(0.24)(0.31)------
Diluted EPS(0.41)(0.76)(0.98)(0.30)(0.11)(0.56)1.61(0.29)(0.53)(0.62)(20.86)2.72(1.83)(0.16)(1.12)(0.24)(0.31)------

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(1.43)(1.18)(1.58)(0.26)(0.50)(0.97)0.36(1.72)(1.11)(1.87)(1.54)(6.93)(6.55)(6.21)(7.04)(9.91)(10.82)(12.83)(8.63)(7.92)
Capital Expenditures0.000.07------------------------0.000.00----0.000.01
Free Cash Flow*(1.43)(1.24)------------------------(7.04)(9.91)----(8.63)(7.93)
Investing Cash Flow0.00(0.07)--------0.000.000.00--0.0010.40----0.000.000.000.000.00(0.01)
Financing Cash Flow0.000.830.251.83(0.13)1.380.000.000.00--0.000.005.02--0.010.000.020.000.090.04

* Derived from reported values